https://www.taxtmi.com/caselaws?id=277682 The Tribunal dismissed the Revenue's appeals, upholding the CIT(A)'s decision to allow the weighted deduction under Section 35(2AB) for clinical trials conducted outside the in-house R&D facility, including Rates & Taxes and Travelling Expenses. The Tribunal relied on the Gujarat High Court decision in Cadila Healthcare Ltd., and other judicial pronouncements, emphasizing that expenditures on clinical trials necessary for product development should be eligible for weighted deduction, irrespective of whether they were incurred within or outside the in-house R&D facility. en-us Fri, 20 Jul 2018 00:00:00 +0530 Tue, 18 Dec 2018 05:55:51 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=277682 The Tribunal dismissed the Revenue's appeals, upholding the CIT(A)'s decision to allow the weighted deduction under Section 35(2AB) for clinical trials conducted outside the in-house R&D facility, including Rates & Taxes and Travelling Expenses. The Tribunal relied on the Gujarat High Court decision in Cadila Healthcare Ltd., and other judicial pronouncements, emphasizing that expenditures on clinical trials necessary for product development should be eligible for weighted deduction, irrespective of whether they were incurred within or outside the in-house R&D facility. Case-Laws Income Tax Fri, 20 Jul 2018 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=277682